Insurable Interest

Insurable interest in insurance refers to the relationship between the policyholder and the insured object, which must exist at the time the policy is purchased. It is the legal right to insure something or someone based on the potential financial loss that would occur if the object or person is damaged or lost. The concept of insurable interest is an important principle of insurance and helps prevent fraud and speculation.

 

For example, a person has an insurable interest in their own life, property they own, or their employees. A parent may have an insurable interest in their child's life or health, and a creditor may have an insurable interest in the life of a debtor to whom they have lent money.

 

Key features of insurable interest include:

 

·      Relationship: The policyholder must have a close relationship with the insured object or person. This could be a family relationship, ownership interest, or financial interest.

 

·      Financial Loss: The policyholder must have a potential financial loss that would result if the insured object or person is damaged or lost.

 

·      Legality: The insurable interest must be legal and not based on fraud or speculation.

 

·      Existence: The insurable interest must exist at the time the policy is purchased and continue throughout the policy term.

 

Insurable interest is a fundamental principle of insurance that ensures the policyholder has a financial stake in the object or person being insured. Without insurable interest, insurance policies would be open to abuse and speculation, which could lead to fraudulent claims and losses for insurance companies.

Next Up

According to Mployer Insights’ 2026 analysis of 76,000+ employer benefit plans, disability insurance remains a major market differentiator, with only 41% of U.S. employers offering short-term disability (STD) and 38% offering long-term disability (LTD). While 60% salary replacement serves as the national standard across both benefit types, standard plan designs disproportionately expose higher earners due to median benefit caps of $1,602/week for STD and $8,273/month for LTD. Furthermore, alignment between STD benefit durations (median 26 weeks) and LTD elimination periods (68% at 90 days) remains a critical area for plan structure optimization.
Welcome to our latest release. We are excited for you to try the new features.
According to Mployer Insights’ 2026 analysis of 50,000+ employer health plans, prescription drugs account for over 25% of total benefit expenses, with Tier 4 specialty drugs driving the majority of high-cost claims. While Tier 4 copays average $123 with coinsurance requirements in 31% of plans, individual oncology therapies like Darzalex Faspro ($170,800/yr) and Keytruda ($158,200/yr) frequently exceed average individual stop-loss deductibles ($141,938). To mitigate exposure, self-funded employers are increasingly turning to independent, transparent PBM models and biosimilar substitution—which yields up to a 73% net cost reduction per patient.